Live feed
Filing
SC 13G
SC 13G0001144204-15-008026·Foresite Capital Fund II, L.P.
Schedule 13G ownership disclosure
Nexvet Biopharma plc
Security class unavailable · CUSIP: G6503X109
Event date: 2015-02-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 908,333
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-008026
- Form type
- SC 13G
- Filer
- Foresite Capital Fund II, L.P.
- CIK
- CIK 1594914
- Filed
- Feb 11, 2015
- Reporting period
- Feb 05, 2015
- Description
- Schedule 13G beneficial ownership